We are live on
!
Find out more
Vertex Pharmaceuticals
VRTX
VRTX
403 hedge funds and large institutions have $16.8B invested in Vertex Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 156 increasing their positions, 133 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
81% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 37
72% more call options, than puts
Call options by funds: $361M | Put options by funds: $210M
17% more repeat investments, than reductions
Existing positions increased: 156 | Existing positions reduced: 133
7% more funds holding
Funds holding: 376 → 403 (+27)
2% less capital invested
Capital invested by funds: $17.1B → $16.8B (-$266M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
403
Holders Change
+27
Holders Change %
+7.18%
% of All Funds
13.07%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.19%
New
67
Increased
156
Reduced
133
Closed
37
Calls
$361M
Puts
$210M
Net Calls
+$151M
Net Calls Change
+$19.2M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$306M |
| 2 |
State Street
Boston,
Massachusetts
|
+$174M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$109M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$85M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$82.6M |
